Correlation Between Foghorn Therapeutics and Structure Therapeutics
Can any of the company-specific risk be diversified away by investing in both Foghorn Therapeutics and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Foghorn Therapeutics and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Foghorn Therapeutics and Structure Therapeutics American, you can compare the effects of market volatilities on Foghorn Therapeutics and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Foghorn Therapeutics with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Foghorn Therapeutics and Structure Therapeutics.
Diversification Opportunities for Foghorn Therapeutics and Structure Therapeutics
0.89 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Foghorn and Structure is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Foghorn Therapeutics and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and Foghorn Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Foghorn Therapeutics are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of Foghorn Therapeutics i.e., Foghorn Therapeutics and Structure Therapeutics go up and down completely randomly.
Pair Corralation between Foghorn Therapeutics and Structure Therapeutics
Given the investment horizon of 90 days Foghorn Therapeutics is expected to generate 2.07 times less return on investment than Structure Therapeutics. In addition to that, Foghorn Therapeutics is 1.14 times more volatile than Structure Therapeutics American. It trades about 0.02 of its total potential returns per unit of risk. Structure Therapeutics American is currently generating about 0.04 per unit of volatility. If you would invest 2,370 in Structure Therapeutics American on November 2, 2024 and sell it today you would earn a total of 685.00 from holding Structure Therapeutics American or generate 28.9% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Foghorn Therapeutics vs. Structure Therapeutics America
Performance |
| Timeline |
| Foghorn Therapeutics |
| Structure Therapeutics |
Foghorn Therapeutics and Structure Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Foghorn Therapeutics and Structure Therapeutics
The main advantage of trading using opposite Foghorn Therapeutics and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Foghorn Therapeutics position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.| Foghorn Therapeutics vs. C4 Therapeutics | Foghorn Therapeutics vs. Prelude Therapeutics | Foghorn Therapeutics vs. Rezolute | Foghorn Therapeutics vs. Shattuck Labs |
| Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |